Evidence map›Paper›PMID 35487502›Full record

ArticleACS applied materials & interfaces2022

SERS and Fluorescence-Active Multimodal Tessellated Scaffolds for Three-Dimensional Bioimaging.

Elisa Lenzi, Dorleta Jimenez de Aberasturi, Malou Henriksen-Lacey, Paula Piñeiro, Ayse J Muniz, Joerg Lahann, Luis M Liz-Marzán

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Growing Gold Nanostars on 3D Hydrogel Surfaces.Chemistry of materials : a publication of the American Chemical Society · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Direct Bottom-UpChemical reviews · 2023
    Review
  10. Review
  11. Raman Spectroscopy as a Tool to Study the Pathophysiology of Brain Diseases.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elisa LenziCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.
Dorleta Jimenez de AberasturiCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.ORCID 0000-0001-5009-3557
Malou Henriksen-LaceyCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.
Paula PiñeiroCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.
Ayse J MunizBiointerfaces Institute, Department of Chemical Engineering, Materials Science and Engineering, Biomedical Engineering Macromolecular Science and Engineering B10-A175 NCRC University of Michigan, 2800 Plymouth Road, Ann Arbor, Michigan 48109-2800, United States.
Joerg LahannBiointerfaces Institute, Department of Chemical Engineering, Materials Science and Engineering, Biomedical Engineering Macromolecular Science and Engineering B10-A175 NCRC University of Michigan, 2800 Plymouth Road, Ann Arbor, Michigan 48109-2800, United States.ORCID 0000-0002-3334-2053
Luis M Liz-MarzánCIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.ORCID 0000-0002-6647-1353

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the ever-increasing use of 3D cell models toward studying bio-nano interactions and offering alternatives to traditional 2D

Indexed as

GoldMetal NanoparticlesFluorescent DyesGlycolsSpectrum Analysis, RamanFluorescent DyesGlycolsGold3D bioprintingmultimodal imagingscaffoldsSERS imagingSERS tags

Identifiers

PMID35487502
PMCPMC9100500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.